Sort
21,453 grants matching “tuberculosis”
GENERAL CLINICAL RESEARCH CENTER
$3,299,255New York University School Of Medicine · M01 · FY2000 · RR
HIV, TB, and Malaria Vaccine Development for Africa
$3,297,293Barton F Haynes · Duke University · P01 · FY2006 · AI
PHRU-Setshaba Clinical Trials Unit
$3,297,099Glenda E Gray · Wits Health Consortium (Pty), Ltd · UM1 · FY2022 · AI
Gerome Wide Association Study of Bacterial Determinants of Clinical Response in Tuberculosis
$3,295,921Megan B Murray · Harvard Medical School · U19 · FY2023 · AI
PS05-003, TUBERCULOSIS CONTROL PROGRAM AND AIDS
$3,293,620John C Grabau · Nysdoh/Health Research, Inc. · U52 · FY2007 · PS
HIV, TB, and Malaria Vaccine Development for Africa
$3,284,182Barton F Haynes · Duke University · P01 · FY2007 · AI
Role of Ubiquitin Ligases and Deubiquitinases in Host Defense against Mycobacterium tuberculosis
$3,278,392Michael Shiloh · Ut Southwestern Medical Center · R01 · FY2025 · AI
Systematic Development of Antiretroviral Intravaginal Rings for HIV Prevention
$3,274,930Marc Michael Baum · Oak Crest Institute Of Science · U19 · FY2014 · AI
Informing Drug Synergy: Investigating Mycobacterial Membrane Protein Structure and Function
$3,262,539Elizabeth Hesper Rego · Yale University · R01 · FY2025 · AI
Transmission Aerobiology of M. tuberculosis: Genes and Metabolic Pathways That Sustain Mtb Across an Evolutionary Bottleneck
$3,258,815Kyu Y Rhee · Weill Medical Coll Of Cornell Univ · P01 · FY2021 · AI
Metabolic factors that control the spectrum of human tuberculosis
$3,253,765David Branch Moody · Brigham And Women'S Hospital · U19 · FY2018 · AI
UAB-ZAMBIA-HAITI HIV PREVENTION TRIALS UNIT
$3,253,539University Of Alabama At Birmingham · U01 · FY2005 · AI
Reagent Program for HIV and other Infectious Diseases
$3,250,651Sujatha Rashid · American Type Culture Collection · N01 · FY2021 · AI
Caribbean, Central, and South America network for HIV Epidemiology (CCASAnet)
$3,250,000Catherine C McGowan · Vanderbilt University Medical Center · U01 · FY2021 · AI
Terry Beirn CPCRA Clinical Trials Unit
$3,249,978Fred M Gordin · George Washington University · UM1 · FY2014 · AI
Reagent Program for HIV and other Infectious Diseases
$3,248,336Sujatha Rashid · American Type Culture Collection · N01 · FY2022 · AI
METABOLIC ALDEHYDES AS IMMUNE EFFECTORS AGAINST TUBERCULOSIS
$3,246,637Katerina Heran Darwin · New York University School Of Medicine · R01 · FY2025 · AI
HIV CENTERS FOR UNDEREPRESENTED POPULATIONS IN RESEARCH CTU (HIV CURE CTU)
$3,241,549Stephen A Spector · University Of California, San Diego · UM1 · FY2020 · AI
Tuberculosis Research Unit
$3,240,332W. Henry Boom · Case Western Reserve University · N01 · FY2013 · AI
Weill Cornell Medicine - Rutgers New Jersey Medical School Clinical Trials Unit
$3,238,675Roy M Gulick · Weill Medical Coll Of Cornell Univ · UM1 · FY2024 · AI
Human immune signatures of Dengue virus and Mycobacterium Tuberculosis exposure in infection, disease and vaccination
$3,238,555Alessandro Sette · La Jolla Institute For Immunology · U19 · FY2017 · AI
Tuberculosis Imaging Program
$3,238,062Steven Holland · National Institute Of Allergy And Infectious Diseases · ZIC · FY2025 · AI
Weill Cornell Medicine - Rutgers New Jersey Medical School Clinical Trials Unit
$3,235,110Roy M Gulick · Weill Medical Coll Of Cornell Univ · UM1 · FY2023 · AI
UCSD Collaborative Clinical Trials Unit
$3,234,709Constance Ann Benson · University Of California, San Diego · UM1 · FY2023 · AI
Emory-CDC CTU
$3,234,078Colleen F Kelley · Emory University · UM1 · FY2025 · AI